Fractyl Health, Inc. (GUTS)
NASDAQ
Delayed Data
Oct 22, 2026, 01:30 PM
Day's Range
1.1252 wk Range
1.11Overview - GUTS - Fractyl Health, Inc.
Key Statistics
Valuation
Enterprise Value
69.70M
P/E (Trailing)
-4.78
P/E (Forward)
-0.88
PEG Ratio
0.06
Price / Book
-419.25
EV / EBITDA
-0.82
Profitability
Profit Margin
0.00%
Operating Margin
0.00%
Return on Assets
-74.57%
Return on Equity
-1,490.31%
Ownership
Shares Outstanding
158.64M
Float
12.14M
Short % of Shares Outstanding
1.80%
Held by Insiders
1.45%
Held by Institutions
51.50%
Price stats
Beta
2.41
50-Day Avg
7.50
200-Day Avg
9.88
Analyst Consensus
7 analysts
Average price target
$ 5.03Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - GUTS - Fractyl Health, Inc.
Peers - GUTS - Fractyl Health, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- GUTSNASDAQFractyl Health, Inc.58.63MMarket Cap-263.80%52-week change-4.79P/E (Trailing)0.00%Profit Margin
- ARGXNASDAQArgenx SE51.51BMarket Cap-3.70%52-week change31.22P/E (Trailing)32.26%Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.31.02BMarket Cap-111.89%52-week change39.09P/E (Trailing)16.12%Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share22.03BMarket Cap-23.08%52-week change160.80P/E (Trailing)-63.63%Profit Margin
- ASNDNASDAQAscendis Pharma A/S14.82BMarket Cap+8.90%52-week change17.26P/E (Trailing)70.84%Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.12.97BMarket Cap+15.27%52-week change-17.56P/E (Trailing)-97.02%Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.10.58BMarket Cap+1.57%52-week change147.76P/E (Trailing)2.14%Profit Margin
Profile Summary - GUTS - Fractyl Health, Inc.
About
Fractyl Health, Inc. is a metabolic therapeutics company focused on developing treatments for obesity and type 2 diabetes. Its current work centers on approaches that address the root causes of metabolic disease rather than only managing symptoms, with a primary emphasis on gut-based therapies. The company’s lead…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
